Hematology Oncology Consultants Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2003
NCT00159094
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Alternative names

Hematology Oncology Consultants, Inc